Volume 42, no. 4, p. 987–988, 1998. The following drug should be added to the table:
Table.
| Date of approval | Trade name (form) | Generic name | Manufacturer | Indications or use |
|---|---|---|---|---|
| 4 Dec 97 | Omnicef (capsules and suspension) | Cefdinir | Parke-Davis | In adults and adolescents: treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis and tonsillitis, and uncomplicated skin and skin structure infections. In pediatric patients: acute bacterial otitis, pharyngitis and tonsillitis, and uncomplicated skin and skin structure infections |